# Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

> **NCT03537547** · PHASE4 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 6 (actual)

## Conditions studied

- Major Depressive Disorder
- Depression
- Depressive Disorder
- Depressive Episode
- Depression, Unipolar

## Interventions

- **OTHER:** GeneSight Psychotropic test
- **DRUG:** FDA-approved antidepressant or antipsychotic treatment

## Key facts

- **NCT ID:** NCT03537547
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-04
- **Primary completion:** 2019-08-19
- **Final completion:** 2019-08-19
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Per sponsor and PI institution discussions
- **Last updated:** 2020-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03537547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03537547, "Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03537547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*